Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donato Teutonico

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
ACS Pharmacology & Translational Science|January 15, 2026
Prediction of Monoclonal Antibodies Pharmacokinetics in Human: Identification of a Reference Neonatal Fc Receptor (FcRn) Binding Affinity Using Physiologically Based Pharmacokinetic (PBPK) ModelingSalih Benamara, Erik Sjögren, Florence Gattacceca, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 4, 2026
Best Practices in Physiologically Based Pharmacokinetic (PBPK) ModelingMarylore Chenel, Andre Dallmann, Ibrahim Ince, et al.
Clinical Pharmacokinetics|May 9, 2018
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of LifeJan-Frederik Schlender, Donato Teutonico, Katrin Coboeken, et al.
Clinical Pharmacology and Therapeutics|November 15, 2023
Prediction of CYP Down Regulation after Tusamitamab Ravtansine Administration (a DM4-Conjugate), Based on an In Vitro-In Vivo Extrapolation ApproachClemence Pouzin, Donato Teutonico, Nathalie Fagniez, et al.
Journal of Medicinal Chemistry|March 27, 2025
Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in HumansXuelian Jia, Donato Teutonico, Saroj Dhakal, et al.
Scientific Reports|July 26, 2017
Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damageArne Schenk, Ahmed Ghallab, Ute Hofmann, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2023
Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictionsHelena Leonie Hanae Loer, Denise Feick, Simeon Rüdesheim, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 11, 2023
Physiologically-based pharmacokinetic modeling of quinidine to establish a CYP3A4, P-gp, and CYP2D6 drug-drug-gene interaction networkDenise Feick, Simeon Rüdesheim, Fatima Zahra Marok, et al.
Clinical Pharmacology and Therapeutics|February 15, 2025
A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug DevelopmentSimeon Rüdesheim, Helena Leonie Hanae Loer, Denise Feick, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 3, 2025
Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community ConferenceAndré Dallmann, Denise Feick, Pavel Balazki, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
ACS Pharmacology & Translational Science|January 15, 2026
Prediction of Monoclonal Antibodies Pharmacokinetics in Human: Identification of a Reference Neonatal Fc Receptor (FcRn) Binding Affinity Using Physiologically Based Pharmacokinetic (PBPK) ModelingSalih Benamara, Erik Sjögren, Florence Gattacceca, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 4, 2026
Best Practices in Physiologically Based Pharmacokinetic (PBPK) ModelingMarylore Chenel, Andre Dallmann, Ibrahim Ince, et al.
Clinical Pharmacokinetics|May 9, 2018
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of LifeJan-Frederik Schlender, Donato Teutonico, Katrin Coboeken, et al.
Clinical Pharmacology and Therapeutics|November 15, 2023
Prediction of CYP Down Regulation after Tusamitamab Ravtansine Administration (a DM4-Conjugate), Based on an In Vitro-In Vivo Extrapolation ApproachClemence Pouzin, Donato Teutonico, Nathalie Fagniez, et al.
Journal of Medicinal Chemistry|March 27, 2025
Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in HumansXuelian Jia, Donato Teutonico, Saroj Dhakal, et al.
Scientific Reports|July 26, 2017
Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damageArne Schenk, Ahmed Ghallab, Ute Hofmann, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 22, 2023
Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictionsHelena Leonie Hanae Loer, Denise Feick, Simeon Rüdesheim, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 11, 2023
Physiologically-based pharmacokinetic modeling of quinidine to establish a CYP3A4, P-gp, and CYP2D6 drug-drug-gene interaction networkDenise Feick, Simeon Rüdesheim, Fatima Zahra Marok, et al.
Clinical Pharmacology and Therapeutics|February 15, 2025
A Comprehensive CYP2D6 Drug-Drug-Gene Interaction Network for Application in Precision Dosing and Drug DevelopmentSimeon Rüdesheim, Helena Leonie Hanae Loer, Denise Feick, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 3, 2025
Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community ConferenceAndré Dallmann, Denise Feick, Pavel Balazki, et al.
Pageof 3